These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33419385)

  • 1. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of the clinical practice and analysis on the ratioanl prescription of antiarrhythmic drugs in Chinese patients with atrial fibrillation: Results from the Chinese Atrial Fibrillation Registry (CAFR) trial].
    Sun LJ; Du X; Liu SW; He R; Zeng H; Sun C; Li L; Zhang Y; Ma CS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):740-747. PubMed ID: 32957756
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims-Based Report.
    Tardos JG; Ronk CJ; Patel MY; Koren A; Kim MH
    J Am Heart Assoc; 2021 Mar; 10(6):e016792. PubMed ID: 33686868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
    Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
    Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
    Malladi CL; Darden D; Aldaas O; Mylavarapu PS; Eskander M; Lupercio F; Han FT; Hoffmayer KS; Raissi F; Ho G; Krummen D; Feld GK; Hsu JC
    PLoS One; 2021; 16(6):e0253266. PubMed ID: 34166392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
    Kowey PR; Breithardt G; Camm J; Crijns H; Dorian P; Le Heuzey JY; Pedrazzini L; Prystowsky EN; Salette G; Schwartz PJ; Torp-Pedersen C; Weintraub W
    Clin Cardiol; 2010 Mar; 33(3):172-8. PubMed ID: 20235224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 5: Guideline Recommendations: Which AAD and for Whom?
    Deering TF; Reiffel JA; Solomon AJ; Tamirisa KP
    Am J Cardiol; 2023 Oct; 205 Suppl 1():S16-S18. PubMed ID: 37777295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).
    Barnett AS; Kim S; Fonarow GC; Thomas LE; Reiffel JA; Allen LA; Freeman JV; Naccarelli G; Mahaffey KW; Go AS; Kowey PR; Ansell JE; Gersh BJ; Hylek EM; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF.
    Chiang CE; Goethals M; O'Neill JO; Naditch-Brûlé L; Brette S; Gamra H; Zharinov O; Steg PG;
    Europace; 2013 Dec; 15(12):1733-40. PubMed ID: 23858023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
    Friberg L
    Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of antiarrhythmic drug use and safety assessment in Chinese patients with atrial fibrillation].
    He R; Du X; Liu SW; Sun LJ; Li Y; Zeng H; Li YY; Sun C; Zhang Y; Ma CS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):935-939. PubMed ID: 27903390
    [No Abstract]   [Full Text] [Related]  

  • 15. Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
    Humphries KH; Kerr CR; Steinbuch M; Dorian P;
    CMAJ; 2004 Sep; 171(7):741-5. PubMed ID: 15451836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
    Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL
    Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
    Camm J
    Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.
    Lewis WR; Piccini JP; Turakhia MP; Curtis AB; Fang M; Suter RE; Page RL; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):770-7. PubMed ID: 25185244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65.
    D'Angelo RN; Rahman M; Khanna R; Yeh RW; Goldstein L; Yadalam S; Kalsekar I; Tung P; Zimetbaum PJ
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1529-1537. PubMed ID: 33760297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.